Old Web
English
Sign In
Acemap
>
authorDetail
>
Kimberly A. Verdries
Kimberly A. Verdries
Pfizer
Chemistry
Biochemistry
Nitric oxide synthase
In vivo
Biological activity
3
Papers
128
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A new class of selective and potent inhibitors of neuronal nitric oxide synthase.
1999
Bioorganic & Medicinal Chemistry Letters
John A. Lowe
Weimin Qian
Robert A. Volkmann
Steven D. Heck
Jolanta Nowakowski
Robert B. Nelson
Charles E. Nolan
Dane Liston
Karen M. Ward
Stevin H. Zorn
Celeste Johnson
Michelle Vanase
W. Stephen Faraci
Kimberly A. Verdries
James Baxter
Shawn D. Doran
Martin Sanders
Mike Ashton
Peter John Whittle
Mark H. Stefaniak
Show All
Source
Cite
Save
Citations (15)
UK-78,282, a novel piperidine compound that potently blocks the Kv1.3 voltage-gated potassium channel and inhibits human T cell activation
1999
British Journal of Pharmacology
Douglas C. Hanson
A. N. Nguyen
Robert J. Mather
Heiko Rauer
Kevin Koch
Laurence E. Burgess
Rizzi Jp
Carol B. Donovan
Matthew J. Bruns
Paul C. Canniff
Ann C. Cunningham
Kimberly A. Verdries
E. Edward Mena
John Charles Kath
George A. Gutman
Michael D. Cahalan
Stephan Grissmer
K. George Chandy
Show All
Source
Cite
Save
Citations (58)
2-Amino-4-methylpyridine as a potent inhibitor of inducible NO synthase activity in vitro and in vivo.
1996
British Journal of Pharmacology
W S Faraci
Arthur Adam Nagel
Kimberly A. Verdries
Lawrence A. Vincent
H. Xu
L. E. Nichols
J. M. Labasi
E. D. Salter
E.R. Pettipher
Show All
Source
Cite
Save
Citations (55)
1